Acquisition focused on lead clinical-stage program ICT01 in acute myeloid leukemia, where data from the ongoing Phase I/II EVICTION trial showed high treatment response ICT01 has the potential to be a ...
What will it take to be cyber resilient in 2025? To what extent are you dependent on third parties? What do you need to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback